| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1476-5381.1982.TB09328.X |
| P953 | full work available at URL | https://europepmc.org/articles/PMC2044613 |
| http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1476-5381.1982.tb09328.x/fullpdf | ||
| https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1476-5381.1982.tb09328.x | ||
| https://europepmc.org/articles/PMC2044613?pdf=render | ||
| P932 | PMC publication ID | 2044613 |
| P698 | PubMed publication ID | 6182939 |
| P5875 | ResearchGate publication ID | 17010241 |
| P2093 | author name string | C. C. Jordan | |
| J. C. Foreman | |||
| W. Piotrowski | |||
| P2860 | cites work | Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin | Q24671286 |
| Mast cell binding of neurotensin. I. Iodination of neurotensin and characterization of the interaction of neurotensin with mast cell receptor sites | Q39165378 | ||
| The relationship between histamine secretion and45calcium-uptake by mast cells | Q39458453 | ||
| Flare and Itch Induced by Substance P in Human Skin | Q39511292 | ||
| Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation | Q39585795 | ||
| Mast cell binding of neurotensin. II. Molecular conformation of neurotensin involved in the stereospecific binding to mast cell receptor sites | Q40099574 | ||
| The central and peripheral ends of the substance P-containing sensory neurones in the rat trigeminal system | Q40931358 | ||
| The role of the alkaline earth ions in anaphylactic histamine secretion | Q41509431 | ||
| Decrease of substance P in primary afferent neurones and impairment of neurogenic plasma extravasation by capsaicin | Q42630933 | ||
| Experimental immunohistochemical studies on the localization and distribution of substance P in cat primary sensory neurons | Q44350659 | ||
| A specific substance P antagonist blocks smooth muscle contractions induced by non-cholinergic, non-adrenergic nerve stimulation | Q46380348 | ||
| Chemical design of antagonists of substance P | Q46529956 | ||
| Release of histamine from mast cells by vasoactive peptides. | Q50965752 | ||
| Calcium Ionophores and Movement of Calcium Ions following the Physiological Stimulus to a Secretory Process | Q59068128 | ||
| Immunohistochemical evidence for separate populations of somatostatin-containing and substance P-containing primary afferent neurons in the rat | Q68218335 | ||
| Neurotensin-induced release of histamine from rat mast cells in vitro | Q70500879 | ||
| Inhibition of acid secretion from vagally innervated and denervated gastric pouches by (Gln4)-neurotensin | Q71224510 | ||
| The in vitro effect of neurotensin on human jejunal mast cells | Q71379494 | ||
| Compound 48/80 inhibits neurotensin-induced hypotension in rats | Q72453360 | ||
| Synthesis of granuliberin-R and various fragment peptides and their histamine-releasing activities | Q72611465 | ||
| Postocclusive cutaneous vasodilatation mediated by substance P | Q72637197 | ||
| A synthetic peptide as an antagonist of substance P | Q72645212 | ||
| Release of histamine by substance P | Q72645231 | ||
| Inhibition of antidromic and substance P-induced vasodilatation by a substance P antagonist | Q72653340 | ||
| The role of the N-terminal tetrapeptide in the histamine releasing action of substance P | Q72655245 | ||
| Histamine release induced by neurotensin from rat peritoneal mast cells | Q72659213 | ||
| The effects of substance P on histamine and 5-hydroxytryptamine release in the rat | Q72684512 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| mast cell | Q191989 | ||
| P304 | page(s) | 531-539 | |
| P577 | publication date | 1982-11-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Interaction of neurotensin with the substance P receptor mediating histamine release from rat mast cells and the flare in human skin | |
| P478 | volume | 77 |
| Q41742767 | A study of [d-Pro2, d-Phe7, d-Trp9]-substance P and [d-Trp7,9]-substance P as tachykinin partial agonists in the rat colon |
| Q68998151 | Action of the SP2-11 and SP3-11 fragments of substance P on rat peritoneal mast cells |
| Q50793059 | Blood vessels and immunoreactive substance P-containing nerve fibers in rat skin treated topically with clobetasol propionate, a corticosteroid |
| Q42848682 | Characterization of neuropeptide-induced histamine release from human dispersed skin mast cells |
| Q34650833 | Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process |
| Q46306359 | Distribution of vasoactive intestinal polypeptide-like immunoreactivity in the mammalian heart. Interrelation with neurotensin- and substance P-like immunoreactive nerves |
| Q38186004 | Dual roles of substance P: modulator of immune and neuroendocrine functions |
| Q72704000 | Histamine release and vascular changes induced by neuropeptides |
| Q72748904 | Histamine release by neurotensin in the rat hindquarter: Structure-activity studies |
| Q53696766 | Lowering of interstitial fluid pressure after neurogenic inflammation in mouse skin is partly dependent on mast cells. |
| Q38204874 | Mast cells, neuropeptides and inflammation |
| Q39750625 | Neuroimmunology. |
| Q37886967 | Neuropeptide innervation of lymphoid organs |
| Q44821434 | Neuropeptide modulation of leukocyte function |
| Q46896325 | Neuropeptide regulation of immediate and delayed hypersensitivity |
| Q38173434 | Neuropeptides and the pathogenesis of allergy |
| Q34479187 | Neurotensin and CRH interactions augment human mast cell activation |
| Q41132365 | Neurotensin elevates hematocrit and plasma levels of the leukotrienes, LTB4, LTC4, LTD4 and LTE4, in anesthetized rats |
| Q33860316 | Neurotensin mediates rat bladder mast cell degranulation triggered by acute psychological stress |
| Q72740210 | Neurotensin stimulates histamine release from the isolated, spontaneously beating heart of rats |
| Q32066343 | New agents for the medical treatment of interstitial cystitis |
| Q68956113 | On the actions of substance P, somatostatin, and vasoactive intestinal polypeptide on rat peritoneal mast cells and in human skin |
| Q40732950 | Pain management: physiopathology, future research and endpoints |
| Q72739335 | Peptides and histamine release |
| Q42849951 | Plasma protein extravasation induced by mammalian tachykinins in rat skin: influence of anaesthetic agents and an acetylcholine antagonist |
| Q67665540 | Platelet activating factor does not release histamine from human dispersed cutaneous mast cells |
| Q53490901 | Polyethylene particle-induced bone resorption in substance P-deficient mice. |
| Q28079028 | Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases |
| Q52093836 | Studies on the trigeminal antidromic vasodilatation and plasma extravasation in the rat |
| Q71707772 | Study of the activation mechanism of human GRF(1-29)NH2 on rat mast cell histamine release |
| Q68936189 | The histamine-releasing effect of dynorphin and other peptides possessing Arg-Pro sequences |
| Q72734902 | The interaction of cholinomimetics, peptides and compounds 48/80 on histamine secretion from the mast cell |
| Q38164239 | The riddle of cholinergic histamine release from mast cells |
| Q72380165 | The role of non-antigen receptors in mast cell signalling processes |
| Q72734933 | The substance P receptor on rat mast cells and in human skin |
Search more.